|
|
|
| Factors Affecting the Impact |
||
| TTTLTBI |
||
|
|
|
|
|
|
|
| • | Tuberculin skin
testing |
|||||
| • | Prediction
of progression to disease |
|||||
| • | Completion of
therapy and programmatic costs |
|||||
| • | Efficacy of
treatment |
|||||
| • | Safety of
treatment |
|||||